Clinical Stage II or III Esophageal Squamous Cell Carcinoma and Neoadjuvant Chemotherapy: Further Considerations

被引：0
|
作者：
Mine, Shinji [1 ]
机构：
[1] Juntendo Univ Hosp, Dept Esophageal & Gastroenterol Surg, Tokyo, Japan
来源：
ANNALS OF SURGICAL ONCOLOGY | 2024年 / 31卷 / 04期
关键词：
D O I：
10.1245/s10434-024-14940-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2198 / 2199
页数：2
相关论文
共 50 条
  • [1] Clinical Stage II or III Esophageal Squamous Cell Carcinoma and Neoadjuvant Chemotherapy: Further Considerations
    Shinji Mine
    [J]. Annals of Surgical Oncology, 2024, 31 : 2198 - 2199
  • [2] Clinical Stage II or III Esophageal Squamous Cell Carcinoma and Neoadjuvant Chemotherapy: Further Considerations
    Mine, Shinji
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2198 - 2199
  • [3] Neoadjuvant Chemoradiotherapy for Clinical Stage II-III Esophageal Squamous Cell Carcinoma
    Saeki, Hiroshi
    Morita, Masaru
    Nakashima, Yuichiro
    Sonoda, Hideto
    Hashimoto, Kenkichi
    Egashira, Akinori
    Oki, Eiji
    Ohga, Takefumi
    Kakeji, Yoshihiro
    Maehara, Yoshihiko
    [J]. ANTICANCER RESEARCH, 2011, 31 (09) : 3073 - 3077
  • [4] Neoadjuvant Chemoradiotherapy for Stage II or III Esophageal Squamous Cell Carcinoma
    Kawai, Takaharu
    Kochi, Mitsugu
    Fujii, Masashi
    Song, Keio
    Hagiwara, Ken
    Watanabe, Megumu
    Matsuno, Yoritaka
    Suda, Hiroshi
    Yagi, Renpei
    Takayama, Tadatoshi
    [J]. ANTICANCER RESEARCH, 2017, 37 (06) : 3301 - 3306
  • [5] Feasibility study of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil (DCF) for clinical stage II/III esophageal squamous cell carcinoma
    Kato, K.
    Hara, H.
    Daiko, H.
    Igaki, H.
    Hamamoto, Y.
    Nagase, M.
    Kadowaki, S.
    Tahara, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [6] Neoadjuvant Chemoradiation Versus Upfront Esophagectomy in Clinical Stage II and III Esophageal Squamous Cell Carcinoma
    Hsu, Po-Kuei
    Chen, Hui-Shan
    Liu, Chia-Chuan
    Wu, Shiao-Chi
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (02) : 506 - 513
  • [7] Neoadjuvant Chemoradiation Versus Upfront Esophagectomy in Clinical Stage II and III Esophageal Squamous Cell Carcinoma
    Po-Kuei Hsu
    Hui-Shan Chen
    Chia-Chuan Liu
    Shiao-Chi Wu
    [J]. Annals of Surgical Oncology, 2019, 26 : 506 - 513
  • [8] Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma
    Matsuda, S.
    Tsubosa, Y.
    Sato, H.
    Takebayashi, K.
    Kawamorita, K.
    Mori, K.
    Niihara, M.
    Tsushima, T.
    Yokota, T.
    Onozawa, Y.
    Yasui, H.
    Takeuchi, H.
    Kitagawa, Y.
    [J]. DISEASES OF THE ESOPHAGUS, 2017, 30 (02):
  • [9] Final results of feasibility study of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil (DCF) for clinical stage II/III esophageal squamous cell carcinoma
    Hara, H.
    Daiko, H.
    Kato, K.
    Igaki, H.
    Kadowaki, S.
    Tanaka, Y.
    Hamamoto, Y.
    Matsushita, H.
    Nagase, M.
    Hosoya, Y.
    Tahara, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Neoadjuvant or adjuvant chemoradiation therapy for stage II-III esophageal squamous cell carcinoma.
    Chen, Yongshun
    Hao, Daxuan
    Wu, Xiaoyuan
    Yang, Yuanyuan
    He, Chunyu
    Wang, Wen
    Liu, Jinsong
    Wang, Jianhua
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
12345